Sofinnova News
Sofinnova Crossover & Sofinnova Industrial Biotech
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
Sofinnova Partners’ Antoine Papiernik spoke with In Vivo magazine’s William Looney on European #venturecapital, #investment strategy, and more. https://bit.ly/2GIP9rZ @INVIVOnow @BillInVivo
Related Strategy
CrossoverRelated Deal lead
Antoine Papiernik
Related News
Sensorion Announces the Appointment of Louis J. Arcudi III as Chief Financial Officer
GenSight Biologics Reports Cash Position as of September 30, 2026
TISSIUM® Announces First U.S. Patients Treated with the ECLIPSIUM® System in UNITE Clinical Trial
GenSight Biologics Reports Interim Financial Results for the First Half of 2026 and Provides Business Updates
Inventiva Reports Unaudited 2026 First-Half Financial Results and Provides Corporate Update